Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-CA-22-030

Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed)

Closed on October 28, 2022.

Posted
August 24, 2022
Close date
October 28, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $480,332 in first-year total cost, median $480,332.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 RTRB-Y (M1)]1

Most frequent institutions

  1. MAYO CLINIC ROCHESTER1
Competing awards under RFA-CA-22-030 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Cancer Adoptive Cell Therapy (Can-ACT) Network Coordinating Center at Mayo Clinic1U24CA283479-01ASMANN, YAN W.GEYER, SUSAN MICHELLEMAYO CLINIC ROCHESTER, MN$480,332ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
RFA-CA-22-030: Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed) | ScienceDex | ConductScience